The FDA approved a new Lantheus prostate cancer imaging agent. South Carolina's measles cases rise. Medtronic's MiniMed shares drop in Nasdaq debut. A French probe exonerates Nestle in a baby death ...

Some of the most revealing signals about human health are carried in fluids that are almost impossible to measure. Tears, cerebrospinal fluid, and ...

In the International Journal of Extreme Manufacturing, researchers at Jilin University now report a way to measure the ...

CCT400028 has been recognised as a high-quality chemical probe and is recommended by the Chemical Probes Portal as a leading Aurora A degrader for laboratory use. The molecule provides researchers ...

The largest ever study of non-meat diets and cancer risk has found that vegetarian diets are associated with lower risks of several cancers—breast, prostate, kidney and pancreatic cancers, and ...

The global medical cyclotron market shows steady growth, expected to be valued at around US$246.8 million in 2026 and projected to reach US$405.4 million by 2033, with a CAGR of 5.4% during this ...

King Faisal Specialist Hospital and Research Centre (KFSH) in Riyadh has successfully introduced a pioneering high-intensity ...

The global medical cyclotron market shows steady growth, expected to be valued at around US$246.8 million in 2026 and projected to reach US$405.4 million ...

Newly released memos from the FB appear to show that former President Joe Biden knew about the agency's search of President Donald Trump’s Mar-a-Lago property.

"If sharing my experience helps someone find strength or perspective in their own challenges, then that’s something positive.” ...

URO-1, a Greensboro medical device company specialized in prostate and soft tissue cancer diagnostics, is expanding its relationship with Novant Health as a designated vendor for its SUREcore and ...

NHS England has given the green light for abiraterone to be used to treat men with prostate cancer that has not metastasised. It is the first time the drug will be available for these patients in ...